ArticleCureus2026
When the Eyes Go Dark: Transient Cortical Blindness After Primary Percutaneous Coronary Intervention.
Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Transient cortical blindness is a rare neurological complication associated with iodinated contrast media used during coronary angiography and percutaneous coronary intervention (PCI). Although uncommon, its sudden onset may mimic acute stroke, creating diagnostic uncertainty and significant anxiety. We report the case of a 49-year-old woman with a three-year history of type 2 diabetes mellitus who presented with prolonged retrosternal chest pain. ECG revealed ST-segment elevation in the inferior leads, consistent with inferoposterior ST-elevation myocardial infarction. Coronary angiography demonstrated an occlusion of the proximal right coronary artery, and successful primary PCI was performed with restoration of thrombolysis in myocardial infarction 3 flow. Near the end of the procedure, the patient developed acute bilateral blindness, preceded by visual fog, despite stable vital signs and the absence of focal neurological deficits. An urgent brain CT and subsequent MRI with angiographic sequences, performed four hours after symptom onset, were unremarkable. Supportive management with intravenous hydration was initiated, and the patient experienced complete visual recovery within 24 hours. The clinical presentation, normal neuroimaging, and rapid resolution were consistent with contrast-induced cortical blindness, a phenomenon attributed to transient blood-brain barrier disruption and direct neurotoxic effects of contrast agents on the occipital cortex. Although self-limited, recognizing this rare complication is crucial to distinguish it from ischemic stroke or posterior reversible encephalopathy syndrome and to prevent unnecessary interventions. Contrast-induced cortical blindness remains a reversible but impactful complication of PCI, and early recognition, exclusion of alternative diagnoses, supportive care, and patient reassurance are essential for optimal management.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.